New market reports and business deals indicate the minimally invasive surgical market can expect to maximize growth
The business of ultrasound has been booming. New capabilities and new applications have broadened its base, both among new and existing users. Its affordability (as compared to more advanced imaging modalities) and its safety (no radiation) make it an ideal tool in many instances. This is becoming particularly true in the surgical suite, where ultrasound is often a primary modality used during minimally invasive procedures.
According to MarketsandMarkets, Dallas, ultrasound is one of many segments in the market: the minimally invasive surgical device market is classified into handheld instruments, guiding devices, inflation systems, auxiliary devices, ultrasound, x-ray, CT and MR imaging, electrosurgical devices, and robotic-assisted surgery systems.
In general, the market has been dynamic with both steady drivers and intimidating challenges in all of these areas. The difficult economic climate has impacted development, pricing, reimbursement, and capital investment, but an aging population and technological advances have counterbalanced these concerns. Over the next few years, the drivers can be expected to ride over the obstacles. Minimally invasive surgery is becoming a popular option for both physicians and patients. Advantages can include better patient outcomes with shorter recovery times, lower risk of infection, and smaller scars, as well as healthier economic results through shorter hospital stays and fewer complications.

These benefits will likely translate into market dollars. MarketsandMarkets has forecast that from 2011 to 2016, the minimally invasive surgery market will grow with a compound annual growth rate, or CAGR, of 8.2%. Currently, it estimates the market size at $23 billion dollars.
In a separate report, the company broke out ablation procedures, a minimally invasive surgical method that targets diseased (or unnecessary) tissue for destruction or removal. As a subsection of the larger market, the ablation segment is naturally smaller, but still significant with a size of approximately $7.5 billion in 2011. But it too, can be expected to grow, even more quickly than the minimally invasive surgical market: MarketsandMarkets estimates the smaller segment will experience an annual growth rate of 10.5% over the 5-year period from 2011 to 2016. Part of the growth will be attributed to new devices coming on to the market that are expected to offer advanced safety and efficacy. Some of these will likely come from the multinational companies that currently dominate the market and include organizations such as Covidien, Mansfield, Mass; Intuitive Surgical Inc, Sunnyvale, Calif; GE Healthcare, Waukesha, Wis; Philips Healthcare, Andover, Mass; and Siemens Healthcare, Malvern, Pa.
Business Move
Each of these firms will engage its own strategy to preserve and maximize market share. The usual business moves are likely to apply with new product launches and new partnerships to be expected.
More...